EP3373931
Heterósýklísk efnasambönd til meðhöndlunar á sjúkdómi
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.11.2016EP published:
28.9.2022EP application number:
16865156.0
EP translation filed:
28.11.2022Grant published:
15.12.2022EPO information:
European Patent Register
Max expiry date:
10.11.2036Expiry date:
10.11.2026Next due date:
30.11.2026
Title in English:
HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASELanguage of the patent:
English
Timeline
Today
11.11.2016EP application
28.9.2022EP Publication
28.11.2022Translation submitted
15.12.2022Registration published
10.11.2026Expires
Owner
Name:
Oppilan Pharma Ltd.Address:
St. John's Innovation Centre Cowley Road, Cambridge CB4 0WS, GB
Inventor
Name:
MOHAN, RajuAddress:
Encinitas, California 92024, US
Name:
NUSS, JohnAddress:
Carlsbad, CA 92009, US
Name:
HARRIS, JasonAddress:
Carlsbad, CA 92009, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562255041 PDate:
13.11.2015Country:
US
Classification
Categories:
A61K 31/437, C07D 471/04, A61P 1/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 28.11.2022
Expires: 10.11.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 6.11.2023
Expires: 10.11.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 31.10.2024
Expires: 10.11.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 17.11.2025
Expires: 10.11.2026
Payer: Árnason Faktor ehf.